NCT05541471View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetic Drug-drug Interactions Between VX-548, Midazolam, and Digoxin

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

September 22, 2022

Primary Completion Date

April 16, 2023

Study Completion Date

April 28, 2023

Conditions
Pain
Interventions
DRUG

VX-548

Tablets for oral administration.

DRUG

Midazolam

Syrup for oral administration.

DRUG

Digoxin

Tablets for oral administration.

Trial Locations (1)

21225

Baltimore - Early Phase Clinical Unit, Baltimore

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY